Clinical trial
Interventional Platform Study Investigating the Impact of Digital Health Solutions on Health Outcomes and Health-Care Resource Utilization in Participants Receiving Systemic Treatment in Clinical Practice
NCT05694013 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Interventional Platform Study Investigating the Impact of Digital Health Solutions on Health Outcomes and Health-Care Resource Utilization in Participants Receiving Systemic Treatment in Clinical Practice
- Lead sponsor
- Hoffmann-La Roche
- Phase
- Phase 2/3
- Overall status
- Terminated
- Start date
- February 27, 2023
- Completion date
- June 30, 2024
- Enrollment
- 49 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.
cancer